Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516298 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Electronic (PDF)Add to Basket
Hard CopyAdd to Basket
EnterprisewideAdd to Basket
Live Chat Live Help Software for Website

Enzymes in Drug Manufacturing

Business Insights, March 2011, Pages: 128


  Description  
   Table of Contents   
   Companies Mentioned   
    
    
     
  Enquire before Buying   
  Send to a Friend   

Biocatalysis in pharmaceutical manufacturing is being driven by advances in enzyme and genomics technologies that are increasing the breadth of reaction applicability. The environmental benefits of enzymatic catalysis are also a strong influence.

This report examines the benefits and challenges of implementing enzymatic steps in pharmaceutical manufacturing. It covers why enzymes are central to green chemistry and industrial biotechnology.The range of industrial enzymes and sources of innovation are covered, along with numerous case studies of enzymes being successfully employed.

Scope of this research

- Understand why biocatalysis plays a central role in the emerging trend toward green chemistry.

- Appreciate the power of enzymes in controlling the formation of chiral products.

- Learn of the techniques employed to develop non-natural enzymes that are better suited to industrial processes.

- Examine case studies in which enzymes have provided significant benefits during process development and optimization efforts. Identify the likely sources of future advances in developing novel enzymatic catalysis processes.

Research and analysis highlights

Enzymes can replace conventional catalysts in drug manufacturing and give significant gains in terms of reduced raw materials and other inputs by improving efficiency and allowing reactions to take place under milder conditions. Biocatalytic steps often offer a powerful solution to the problem of controlling stereochemistry.

Both green chemistry and industrial biotechnology are important emerging trends worldwide. Enzymes are central to both disciplines so developments are likely to increase the focus on biocatalysis and encourage its wider implementation within industry.

There are many potential sources of innovative enzymes that could meet the needs of pharma. These include organisms from extreme environments and genomic databases. New and old enzymes can be optimized for their properties using technologies such as directed evolution.

Key reasons to purchase this research

- What benefits do enzymes offer compared with conventional chemical synthesis?

- How can an enzymatic steps be integrated into an existing manufacturing process and what are the challenges in so doing?

- Why are enzymes such a key focus in both green chemistry and industrial biotechnology?

- How can a natural enzyme be modified so that its properties are compatible with process conditions typically found in the pharmaceutical industry?

- What sectors of industry currently make the best use of enzymes in their processes and can pharma follow suit?



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds